These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25682479)

  • 1. Profiles of substance use disorders in patients of therapeutic communities: link to social, medical and psychiatric characteristics.
    Fernández-Calderón D; Fernández F; Ruiz-Curado S; Verdejo-García A; Lozano ÓM
    Drug Alcohol Depend; 2015 Apr; 149():31-9. PubMed ID: 25682479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric comorbidity in cocaine users treated in therapeutic community: substance-induced versus independent disorders.
    Vergara-Moragues E; González-Saiz F; Lozano OM; Betanzos Espinosa P; Fernández Calderón F; Bilbao-Acebos I; Pérez García M; Verdejo García A
    Psychiatry Res; 2012 Dec; 200(2-3):734-41. PubMed ID: 22910475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of psychiatric comorbidity on the in-treatment outcomes of cocaine-dependent patients in therapeutic communities.
    González-Saiz F; Vergara-Moragues E; Verdejo-García A; Fernández-Calderón F; Lozano OM
    Subst Abus; 2014; 35(2):133-40. PubMed ID: 24821349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of substance use disorders on clinical outcomes in older-adult psychiatric inpatients.
    Lane SD; da Costa SC; Teixeira AL; Reynolds CF; Diniz BS
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):e323-e329. PubMed ID: 29044798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients.
    John WS; Zhu H; Mannelli P; Schwartz RP; Subramaniam GA; Wu LT
    Drug Alcohol Depend; 2018 Jun; 187():79-87. PubMed ID: 29635217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of decisional capacity: Prevalence of medical illness and psychiatric comorbidities.
    Boettger S; Bergman M; Jenewein J; Boettger S
    Palliat Support Care; 2015 Oct; 13(5):1275-81. PubMed ID: 25355466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service.
    Araos P; Vergara-Moragues E; González-Saiz F; Pedraz M; García-Marchena N; Romero-Sanchiz P; Ruiz JJ; Campos-Cloute R; Serrano A; Pavón FJ; Torrens M; Rodriguez De Fonseca F
    J Psychoactive Drugs; 2017; 49(4):306-315. PubMed ID: 28682218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Psychiatric Hospitalizations of Patients With Dual Diagnosis in Spain.
    Gómez-Sánchez-Lafuente C; Guzman-Parra J; Suarez-Perez J; Bordallo-Aragon A; Rodriguez-de-Fonseca F; Mayoral-Cleries F
    J Dual Diagn; 2022; 18(2):92-100. PubMed ID: 35387575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of psychiatric comorbidity and use of the emergency department among persons with substance use disorders: an observational cohort study.
    Curran GM; Sullivan G; Williams K; Han X; Allee E; Kotrla KJ
    BMC Emerg Med; 2008 Dec; 8():17. PubMed ID: 19055761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric comorbidity and severity of dependence on substance users: how it impacts on their health-related quality of life?
    Lozano ÓM; Rojas AJ; Fernández Calderón F
    J Ment Health; 2017 Apr; 26(2):119-126. PubMed ID: 27128492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data.
    Wu LT; Ghitza UE; Batch BC; Pencina MJ; Rojas LF; Goldstein BA; Schibler T; Dunham AA; Rusincovitch S; Brady KT
    Drug Alcohol Depend; 2015 Nov; 156():162-169. PubMed ID: 26392231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics].
    Rodríguez-Jiménez R; Aragüés M; Jiménez-Arriero MA; Ponce G; Muñoz A; Bagney A; Hoenicka J; Palomo T
    Invest Clin; 2008 Jun; 49(2):195-205. PubMed ID: 18717266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A typology of cannabis-related problems among individuals with repeated illegal drug use in the first three decades of life: Evidence for heterogeneity and different treatment needs.
    Wittchen HU; Behrendt S; Höfler M; Perkonigg A; Rehm J; Lieb R; Beesdo K
    Drug Alcohol Depend; 2009 Jun; 102(1-3):151-7. PubMed ID: 19362792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders.
    Chahua M; Sánchez-Niubò A; Torrens M; Sordo L; Bravo MJ; Brugal MT; Domingo-Salvany A;
    Qual Life Res; 2015 Sep; 24(9):2129-37. PubMed ID: 25682367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender and addiction and other mental disorders comorbidity: sociodemographic, clinical, and treatment differences.
    Fernández SD; Miranda JJF; Pastor FP; Muñoz FL
    Arch Womens Ment Health; 2023 Oct; 26(5):639-650. PubMed ID: 37540344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysubstance use in young people accessing residential and day-treatment services for substance use: substance use profiles, psychiatric comorbidity and treatment completion.
    Mefodeva V; Carlyle M; Walter Z; Chan G; Hides L
    Addiction; 2022 Dec; 117(12):3110-3120. PubMed ID: 35851706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Violence and severe mental disorder in clinical and community populations: the effects of psychotic symptoms, comorbidity, and lack of treatment.
    Swanson J; Estroff S; Swartz M; Borum R; Lachicotte W; Zimmer C; Wagner R
    Psychiatry; 1997; 60(1):1-22. PubMed ID: 9130311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.